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Background:  Prior studies suggest that older adults are less likely to receive guideline-based therapies during ST-elevation myocardial infarction 
(STEMI).
Methods:  Using the Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) database, we examined care and in-hospital outcomes of STEMI 
patients (pts) ≥80 years in 319 centers in the United States from 2000-2009. Use of evidence-based therapies and in-hospital mortality were 
analyzed.
Results:  A total of 5,339 pts aged ≥80 hospitalized with STEMI were included (16% of total STEMI pts). Of these, 42.8% (n=2,285) underwent 
primary PCI (PPCI), 4.8% (N=255) underwent TL (thrombolysis), and 52.4% (2,799) received no reperfusion (NR). Significant differences among 
groups were present (Table). After multivariate adjustment, the mortality and odds of longer hospital stay (LOS) ->4 days- in PPCI-pts were lower 
compared with NR-pts (mortality OR:0.41, 95%CI: 0.35-0.49, p<0.0001; LOS OR:0.77, 95%CI 0.68-0.86, p<0.0001). Also, after multivariate 
adjustment, the mortality and LOS of PPCI or TL pts were significantly lower compared to NR pts (mortality OR:0.47 95%CI: 0.40-0.55, p <0.0001; 
LOS OR:0.81 95%CI 0.73-0.91, p =0.0003).
Conclusions:  Among GWTG-CAD hospitals, the use of evidence-based therapies for STEMI in pts ≥80 was high, particularly in those receiving 
mechanical or pharmacological reperfusion. The use of PPCI or TL compared with NR was associated with lower in-hospital death rates and shorter 
length of stay.
Patient Characteristics Stratified by Reperfusion Strategy
Description
Overall
(n=5,339)
Primary PCI
(n=2,285)
Thrombolysis
(n=255)
None
(n=2,799)
Age, mean +/- SD, y 85.6 +/- 4.5 84.3 +/- 3.7 85.4 +/- 4.3 86.6 +/- 4.8 < 0.001
Men % (n) 39.7 (2,120) 42.0 (959) 42.8 (109) 37.6 (1,052) 0.005
BMI, mean +/- SD, kg/m2 28.5 +/- 6.6 30.2 +/- 6.8 28.2. +/- 6.2 25.4 +/- 5.4 < 0.001
Renal Insufficiency % (n) 12.4 (627) 7.7 (169) 11.3 (27) 16.3 (431) < 0.001
Heart Failure % (n) 21.9 (1,110) 11.7 (256) 21.3 (51) 30.4 (803) < 0.001
Aspirin ≤ 24 h 93.4 (4,365) 96.1 (2,026) 94.6 (209) 90.9 (2,130) < 0.001
Beta-blockers ≤ 24 h 86.9 (3,526) 90.4 (1,619) 86.3 (177) 83.9 (1,730) < 0.001
DTN ≤ 30 minutes, % (n) N/A N/A 21.9 (56) N/A
DTB ≤ 90 minutes, % (n) N/A 36.2 (828) N/A N/A
